Home › Compare › CHMMF vs EQR

CHMMF vs EQR: Dividend Comparison 2026

CHMMF yields 200000.00% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CHMMF wins by $4.911780474428384e+29M in total portfolio value
10 years
CHMMF
CHMMF
● Live price
200000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.911780474428384e+29M
Annual income
$490,695,411,370,591,700,000,000,000,000,000,000.00
Full CHMMF calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — CHMMF vs EQR

📍 CHMMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCHMMFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CHMMF + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CHMMF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHMMF
Annual income on $10K today (after 15% tax)
$17,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$417,091,099,665,002,940,000,000,000,000,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, CHMMF beats the other by $417,091,099,665,002,940,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHMMF + EQR for your $10,000?

CHMMF: 50%EQR: 50%
100% EQR50/50100% CHMMF
Portfolio after 10yr
$2.455890237214192e+29M
Annual income
$245,347,705,685,295,860,000,000,000,000,000,000.00/yr
Blended yield
99.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

CHMMF
No analyst data
Altman Z
-32.8
Piotroski
1/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHMMF buys
0
EQR buys
0
No recent congressional trades found for CHMMF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCHMMFEQR
Forward yield200000.00% ✓5.87%
Annual dividend / share$2.00$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$4.911780474428384e+29M$47.8K ✓
Annual income after 10y$490,695,411,370,591,700,000,000,000,000,000,000.00 ✓$5,475.61
Total dividends collected$4.911464459982279e+29M$23.0K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CHMMF vs EQR ($10,000, DRIP)

YearCHMMF PortfolioCHMMF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$20,010,700$20,000,000.00$11,380$679.82+$20.00M → CHMMF
2$37,424,589,019$37,403,177,570.09$13,014$837.25+$37424.58M → CHMMF
3$65,416,215,188,220$65,376,170,877,969.18$14,961$1,036.20+$65416215.17M → CHMMF
4$106,868,230,495,008,900$106,798,235,144,757,520.00$17,297$1,289.22+$106868230494.99M → CHMMF
5$163,172,871,735,896,870,000$163,058,522,729,267,200,000.00$20,121$1,613.15+$163172871735896.84M → CHMMF
6$232,854,599,801,468,860,000,000$232,680,004,828,711,460,000,000.00$23,561$2,030.84+$232854599801468864.00M → CHMMF
7$310,570,858,137,017,100,000,000,000$310,321,703,715,229,540,000,000,000.00$27,783$2,573.54+$310570858137017057280.00M → CHMMF
8$387,148,154,301,613,200,000,000,000,000$386,815,843,483,406,600,000,000,000,000.00$33,013$3,284.39+$3.871481543016132e+23M → CHMMF
9$451,061,749,763,281,040,000,000,000,000,000$450,647,501,238,178,360,000,000,000,000,000.00$39,547$4,223.51+$4.510617497632811e+26M → CHMMF
10$491,178,047,442,838,440,000,000,000,000,000,000$490,695,411,370,591,700,000,000,000,000,000,000.00$47,791$5,475.61+$4.911780474428384e+29M → CHMMF

CHMMF vs EQR: Complete Analysis 2026

CHMMF — Stock

Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies in oncology in Australia. The company develops CHM 0201 (core NK platform) that is in phase I clinical trial for treating solid tumors and hematological malignancies; and CHM 1101 (CLTX CAR T), which is in phase I clinical trial for treating patients with MMP2+ recurrent or progressive glioblastoma. It is also developing CHM 0301 for blood cancers; CHM 1301 (CLTX CAR NK) and CHM 2301 (CDH17 CAR NK) for solid tumors; CHM 1101 (CLTX CAR T) for melanoma, colorectal, and prostate; and CHM 2101 (CDH17 CAR T) for neuroendocrine, colorectal, pancreatic, and gastric. The company was incorporated in 2020 and is based in Carlton, Australia.

Full CHMMF Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this CHMMF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHMMF vs SCHDCHMMF vs JEPICHMMF vs OCHMMF vs KOCHMMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.